Share this article

 Email

 Print

 

Republish this article

The text of this article by Futurity is licensed under a Creative Commons Attribution-No Derivatives License.

More
Health & Medicine

Quick therapy stomps on fear of spiders

For toddlers, flame retardant risks may vary by race

Got unwanted weight? Blame new neurons

Tiny chip could test for latent TB faster

Marathon death risk low, but double for men

Drug-vaccine combo better for breast cancer

Human study will test drug to prevent Alzheimer’s

Third offspring later, chemical effects linger

Size and stickiness predict stem cell future

Using silver nanoparticles cloaked in a protein from the HIV virus that has an uncanny ability to penetrate human cells, scientists from Duke University have demonstrated that they can enter the inner workings of the nucleus and detect subtle light signals from the “spy.”

In order for these nano-spies to be effective, they not only need to get through the cell’s first line of defense—the cell wall—they must be able to enter the nucleus.

The ultimate goal is to be able to spot the earliest possible moment when the genetic material within a cell begins to turn abnormal, leading to a host of disorders, especially cancer.

The finding also shows how drugs or other payloads might be delivered directly into the nucleus.

“This new method of getting into and detecting exactly what is going on in the nucleus of cell has distinct advantages over current methods,” says graduate student Molly Gregas.

“The ability to place these nanoparticles into a cell’s nucleus and gather information using light has potential implications for the selective treatment of disease,” Gregas says.

Duke biomedical engineer Tuan Vo-Dinh (left) and graduate student Molly Gregas are developing a way to sneak nanoparticles into living cells by cloaking them in some proteins from the HIV virus. (Credit: Duke)

“We envision that this approach will also help basic scientists as they try to better understand what occurs within a cell’s nucleus.”

The researchers reported their findings in a series of papers, culminating in the latest issue of Nanomedicine. The research was supported by the National Institutes of Health.

The researchers coupled miniscule particles of silver, a metal that is not rejected by cells and is an efficient reflector of light, with a small portion of the HIV protein responsible for its highly efficient ability to enter a cell and its nucleus.

In this case, the researchers harnessed only the ability of HIV to sneak past cellular defenses, while stripping away its ability to take over the cell’s genetic machinery and cause disease.

“This combination takes advantage of the smallness of the nanoparticle and the ‘delivery instructions’ of the HIV protein,” Gregas explains. “Once we can get that nanoparticle into the nucleus, we have many options. We can for example deliver some sort of payload and then observe its effects within the nucleus.”

That’s where a four-decades-old optical technique known as surface-enhanced Raman scattering (SERS) comes into play. It is used here as a sensitive imaging technique to demonstrate that the nanoparticles and their payloads successfully entered the nucleus.

When light, usually from a laser, is shined on a sample, the target molecule vibrates and scatters back its own unique light, often referred to as the Raman scatter. However, this Raman response is extremely weak.

When the target molecule is coupled with a metal nanoparticle, the Raman response is greatly enhanced by the SERS effect—often by more than a million times, says Tuan Vo-Dinh, professor of biomedical engineering and chemistry.

“Our ultimate goal is to develop a nanoscale delivery system that can drop off its payload—in this case nanoparticles with other agents attached—into a cell to enhance the effectiveness of a drug treatment,” says Vo-Dinh.

“Theoretically, we could ‘load up’ these nanoparticles with many things we are interested in—for example a nanoprobe for a cancer gene—and get it into a cell’s nucleus. This would provide us a warning signal of the disease at its earliest stage, thus allowing faster and more effective treatment.”

The current experiments were conducted with living cells in the laboratory. New experiments are focusing on using this approach in animal models to determine how it works in a complex living system.

More news from Duke: www.dukenews.duke.edu